Ultragenyx Pharmaceutical
RARE
#4143
Rank
C$4.29 B
Marketcap
C$43.58
Share price
-0.26%
Change (1 day)
-12.39%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: C$4.29 Billion

As of June 2026 Ultragenyx Pharmaceutical has a market cap of C$4.29 Billion. This makes Ultragenyx Pharmaceutical the world's 4143th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026C$4.29 B-4.98%
2025C$4.51 B-21.49%
2024C$5.75 B10.47%
2023C$5.20 B18.17%
2022C$4.40 B-39.66%
2021C$7.30 B-37.44%
2020C$11.67 B261.93%
2019C$3.22 B7.1%
2018C$3.01 B21.3%
2017C$2.48 B-35.67%
2016C$3.86 B-36.19%
2015C$6.05 B272.08%
2014C$1.62 B

End of Day market cap according to different sources

On Jun 28th, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be:

C$4.30 Billion
by Nasdaq info icon info icon
C$4.30 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Lexicon Pharmaceuticals
LXRX
C$1.67 B-61.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$1.15 B-73.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$6.46 B 50.53%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$15.70 B 265.89%๐Ÿ‡บ๐Ÿ‡ธ USA